A new study led by researchers suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs. The researchers are from the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). The findings of the laboratory and animal study, published in the ...
via Medindia Health News
More READ
No comments:
Post a Comment